巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Processa Pharmaceuticals

    PCSA
    1.910
    0.070
    3.54%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Processa Pharmaceuticals - 延遲價格・最後更新於 26/09 12:00
    最高位
    1.920
    最低位
    1.890
    開市價
    --
    前收市價
    1.980
    成交量(千)
    1.28
    成交額(百萬)
    0.02
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    30.29
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    8.991 - 1.500
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Processa Pharmaceuticals
    證券代碼
    PCSA.US
    所屬板塊
    Biotechnology
    公司業務
    Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100.
    發行量
    20582615
    公司總部
    7380 Coca Cola Drive, Suite 106
    公司網址
    https://www.processapharmaceuticals.com
    公司電話
    +1 443 776-3133
    暫無內容

    關於

    Processa Pharmaceuticals(PCSA.US)所屬的行業板塊為Biotechnology。
    Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100.
    詳細公司背景可參考: https://www.processapharmaceuticals.com